Heat Biologics, Inc (NASDAQ: HTBX) is a biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system. The company's gp96 platform is designed to activate immune responses against cancer or infectious diseases. The Company has multiple product candidates in development leveraging the gp96 platform, including HS-110, which has completed enrollment in its Phase 2 trial, and a COVID-19 vaccine program in preclinical development. In addition, Heat is also developing a pipeline of proprietary immunomodulatory antibodies and cell-based therapies, including PTX-35 and HS-130 in Phase 1 clinical trials.
Location: United States, North Carolina, Durham
Member count: 11-50
Phone: +1 919-240-7133
Total raised: $9M
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | Seed-One C... | seedone.co... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 17.04.2013 | - | $5M | - | medcitynew... |
| 03.01.2012 | - | $4M | - | medcitynew... |
Mentions in press and media 17
| Date | Title | Description | Category | Author | Source |
| 12.04.2021 | HEAT BIOLO... | Heat Biologics Announces New P... | - | - | marketscre... |
| 09.02.2021 | HEAT BIOLO... | February 9, 2021 Heat Biologi... | - | - | marketscre... |
| 09.02.2021 | Heat Biolo... | February 9, 2021 Heat Biologi... | - | - | marketscre... |
| 16.04.2020 | Covid-19 v... | By Jeff Craven Currently, t... | - | Endpoints ... | endpts.com... |
| 09.04.2020 | Covid-19 T... | By Jeff Craven On March 11, t... | - | Endpoints ... | endpts.com... |
| 07.04.2016 | Heat Biolo... | Another day, another biotech a... | Biotech | - | fiercebiot... |
| 17.04.2013 | Heat Biolo... | Unlike other immunotherapies t... | - | - | medcitynew... |
| 16.02.2012 | Life scien... | Heat Bio. Heat’s lead drug pro... | - | - | medcitynew... |
| 15.02.2012 | Pharmas, m... | A total of 16 companies are sc... | - | - | medcitynew... |
| 12.01.2012 | Vaccine bi... | Heat is in phase 2 clinical tr... | - | - | medcitynew... |
Show more